December 31, 2024 | December 31, 2023 | ||||||||||
(Unaudited) | |||||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 198,240 | $ | 95,260 | |||||||
Accounts receivable, net of allowances of $726 and $203 as of December 31, 2024 and 2023, respectively | 23,159 | 4,050 | |||||||||
Contract assets and unbilled revenue, net | 26,645 | 11,780 | |||||||||
Other current assets | 7,476 | 2,452 | |||||||||
Total current assets | 255,520 | 113,542 | |||||||||
Restricted cash equivalents, non-current | 676 | 13,775 | |||||||||
Right-of-use assets | 4,692 | 5,210 | |||||||||
Property and equipment, net | 1,239 | 1,515 | |||||||||
Goodwill | 101,704 | — | |||||||||
Intangible assets, net | 174,943 | — | |||||||||
Deferred tax asset | 4 | 11 | |||||||||
Contract assets and unbilled revenue, non-current, net | 12,879 | 16,492 | |||||||||
Other non-current assets | 2,296 | 577 | |||||||||
Total assets | $ | 553,953 | $ | 151,122 | |||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | 5,559 | $ | 1,653 | |||||||
Accrued liabilities | 26,291 | 13,884 | |||||||||
Operating lease liabilities | 1,898 | 2,637 | |||||||||
Finance lease liabilities | 49 | 121 | |||||||||
Income tax liability | 2,750 | 1,618 | |||||||||
Deferred revenue | 23,876 | 4,310 | |||||||||
Other current liabilities | 7,319 | — | |||||||||
Total current liabilities | 67,742 | 24,223 | |||||||||
Operating lease liabilities, net of current portion | 2,403 | 3,089 | |||||||||
Deferred revenue, net of current portion | 6,862 | 4,910 | |||||||||
Long-term debt | — | 84,312 | |||||||||
Contingent acquisition liabilities | 286,898 | — | |||||||||
Income tax liability, net of current portion | 3,075 | 2,453 | |||||||||
Other non-current liabilities | 4,320 | 3,967 | |||||||||
Total liabilities | 371,300 | 122,954 | |||||||||
Commitments and contingencies | |||||||||||
Stockholders’ equity (deficit): | |||||||||||
Series A Preferred Stock, $0.0001 par value; 1,000,000 shares authorized; 0 and 475,005 shares issued and outstanding, aggregate liquidation preference of $— and $16,227 as of December 31, 2024 and December 31, 2023, respectively | — | 14,187 | |||||||||
Class A Common Stock, $0.0001 par value; 455,000,000 shares authorized; 361,096,457 and 216,943,349 shares issued and outstanding as of December 31, 2024 and 2023, respectively | 35 | 22 | |||||||||
Class B Common Stock, $0.0001 par value; 44,000,000 shares authorized; 32,535,408 and 37,485,408 shares issued and outstanding as of December 31, 2024 and 2023, respectively | 3 | 4 | |||||||||
Additional paid-in capital | 1,125,470 | 606,135 | |||||||||
Accumulated deficit | (943,060) | (592,379) | |||||||||
Accumulated other comprehensive income | 205 | 199 | |||||||||
Total stockholders’ equity (deficit) | 182,653 | 28,168 | |||||||||
Total liabilities and stockholders’ equity (deficit) | $ | 553,953 | $ | 151,122 |
Three Months Ended December 31, | |||||||||||
2024 | 2023 | ||||||||||
Revenues | $ | 34,543 | $ | 17,147 | |||||||
Operating expenses: | |||||||||||
Cost of revenues | 20,759 | 3,911 | |||||||||
Sales and marketing | 9,566 | 4,469 | |||||||||
Research and development | 20,394 | 12,713 | |||||||||
General and administrative | 16,437 | 7,641 | |||||||||
Change in fair value of contingent acquisition liabilities | 220,946 | — | |||||||||
Amortization of intangible assets | 3,513 | — | |||||||||
Restructuring | — | 806 | |||||||||
Total operating expenses | 291,615 | 29,540 | |||||||||
Operating loss | (257,072) | (12,393) | |||||||||
Other expense, net: | |||||||||||
Loss on early extinguishment of debt | (42) | — | |||||||||
Interest expense | (1,309) | (5,460) | |||||||||
Other income (expense), net | 135 | 1,457 | |||||||||
Total other expense, net | (1,216) | (4,003) | |||||||||
Loss before provision for income taxes | (258,288) | (16,396) | |||||||||
Provision for income taxes | 311 | 1,607 | |||||||||
Net loss | $ | (258,599) | $ | (18,003) | |||||||
Cumulative dividends attributable to Series A Preferred Stock | — | (568) | |||||||||
Net loss attributable to SoundHound common shareholders | $ | (258,599) | $ | (18,571) | |||||||
Other comprehensive income: | |||||||||||
Unrealized gains (losses) on investments | (57) | 2 | |||||||||
Comprehensive loss | $ | (258,656) | $ | (18,569) | |||||||
Net loss per share: | |||||||||||
Basic and diluted | $ | (0.69) | $ | (0.07) | |||||||
Weighted-average common shares outstanding: | |||||||||||
Basic and diluted | 375,102,329 | 248,250,552 |
Year Ended December 31, | |||||||||||||||||
2024 | 2023 | 2022 | |||||||||||||||
(Unaudited) | |||||||||||||||||
Revenues | $ | 84,693 | $ | 45,873 | $ | 31,129 | |||||||||||
Operating expenses: | |||||||||||||||||
Cost of revenues | 43,309 | 11,307 | 9,599 | ||||||||||||||
Sales and marketing | 29,126 | 18,893 | 20,367 | ||||||||||||||
Research and development | 70,555 | 51,439 | 76,392 | ||||||||||||||
General and administrative | 53,270 | 28,285 | 30,443 | ||||||||||||||
Change in fair value of contingent acquisition liabilities | 222,670 | — | — | ||||||||||||||
Amortization of intangible assets | 7,116 | — | — | ||||||||||||||
Restructuring | — | 4,557 | — | ||||||||||||||
Total operating expenses | 426,046 | 114,481 | 136,801 | ||||||||||||||
Loss from operations | (341,353) | (68,608) | (105,672) | ||||||||||||||
Other expense, net: | |||||||||||||||||
Loss on early extinguishment of debt | (15,629) | (837) | — | ||||||||||||||
Interest expense | (12,168) | (16,733) | (6,893) | ||||||||||||||
Other income (expense), net | 9,222 | 1,155 | (1,259) | ||||||||||||||
Total other expense, net | (18,575) | (16,415) | (8,152) | ||||||||||||||
Loss before provision for income taxes | (359,928) | (85,023) | (113,824) | ||||||||||||||
Provision for income taxes | (9,247) | 3,914 | 2,889 | ||||||||||||||
Net loss | (350,681) | (88,937) | (116,713) | ||||||||||||||
Cumulative dividends attributable to Series A Preferred Stock | (416) | (2,774) | — | ||||||||||||||
Net loss attributable to SoundHound common shareholders | (351,097) | (91,711) | (116,713) | ||||||||||||||
Other comprehensive loss: | |||||||||||||||||
Unrealized gains on investments | 6 | 199 | — | ||||||||||||||
Comprehensive loss | $ | (350,675) | $ | (88,738) | $ | (116,713) | |||||||||||
Net loss per share: | |||||||||||||||||
Basic and diluted | $ | (1.04) | $ | (0.40) | $ | (0.74) | |||||||||||
Weighted-average common shares outstanding: | |||||||||||||||||
Basic and diluted | 338,462,574 | 229,264,904 | 157,317,695 |
Year Ended December 31, | |||||||||||||||||
2024 | 2023 | 2022 | |||||||||||||||
(Unaudited) | |||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||
Net loss | $ | (350,681) | $ | (88,937) | $ | (116,713) | |||||||||||
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||||||||
Depreciation and amortization | 16,054 | 2,313 | 4,037 | ||||||||||||||
Stock-based compensation | 33,145 | 27,931 | 28,792 | ||||||||||||||
Loss on change in fair value of ELOC program | — | 1,901 | 1,075 | ||||||||||||||
Change in fair value of derivative and warrant liability | — | — | 606 | ||||||||||||||
Amortization of debt issuance cost | 1,621 | 5,400 | 2,287 | ||||||||||||||
Non-cash lease amortization | 2,613 | 3,346 | 3,189 | ||||||||||||||
Loss on early extinguishment of debt | 15,629 | 837 | — | ||||||||||||||
Foreign currency gain/loss from remeasurement | (24) | 143 | — | ||||||||||||||
Change in fair value of contingent acquisition liabilities | 222,670 | — | — | ||||||||||||||
Deferred income taxes | (12,183) | 30 | 2,127 | ||||||||||||||
Other, net | (580) | 93 | — | ||||||||||||||
Changes in operating assets and liabilities: | |||||||||||||||||
Accounts receivable, net | (10,264) | (627) | (1,354) | ||||||||||||||
Prepaid expenses | — | 1,590 | (1,238) | ||||||||||||||
Other current assets | (3,131) | (821) | 299 | ||||||||||||||
Contract assets | (7,304) | (19,578) | (8,658) | ||||||||||||||
Other non-current assets | (196) | 671 | (274) | ||||||||||||||
Accounts payable | (6,401) | (1,162) | 302 | ||||||||||||||
Accrued liabilities | 611 | 4,266 | 116 | ||||||||||||||
Other current liabilities | (642) | — | — | ||||||||||||||
Operating lease liabilities | (3,214) | (3,657) | (3,912) | ||||||||||||||
Deferred revenue | (6,186) | (4,135) | (7,646) | ||||||||||||||
Other non-current liabilities | (415) | 2,131 | 2,946 | ||||||||||||||
Net cash used in operating activities | (108,878) | (68,265) | (94,019) | ||||||||||||||
Cash flows from investing activities: | |||||||||||||||||
Purchases of property and equipment | (640) | (392) | (1,329) | ||||||||||||||
Payment related to acquisitions, net of cash acquired | (11,732) | — | — | ||||||||||||||
Net cash used in investing activities | (12,372) | (392) | (1,329) | ||||||||||||||
Cash flows from financing activities: | |||||||||||||||||
Proceeds from the issuance of Series A Preferred Stock, net of issuance costs | — | 24,942 | — | ||||||||||||||
Proceeds from sales of Class A common stock under the ELOC program, net of issuance costs | — | 71,615 | — | ||||||||||||||
Proceeds from sales of Class A common stock under the Sales Agreement, Equity Distribution Agreement and Execute Equity Distribution Agreement | 407,270 | 12,412 | — | ||||||||||||||
Proceeds from exercise of stock options and employee stock purchase plan | 29,685 | — | — |
Year Ended December 31, | |||||||||||||||||
2024 | 2023 | 2022 | |||||||||||||||
(Unaudited) | |||||||||||||||||
Proceeds from warrants exercised | 23 | — | — | ||||||||||||||
Payment of financing costs associated with the Sales Agreement, Equity Distribution Agreement and Execute Equity Distribution Agreement | (10,357) | — | — | ||||||||||||||
Proceeds from the issuance of debt, net of issuance costs | — | 85,087 | — | ||||||||||||||
Proceeds from the issuance of common stock | — | 9,369 | 4,160 | ||||||||||||||
Proceeds from Business Combination and PIPE, net of transaction costs | — | — | 90,689 | ||||||||||||||
Payments on notes payable | (215,373) | (35,029) | (11,545) | ||||||||||||||
Payment to settle contingent holdback liabilities from SYNQ3 acquisition | (217) | — | — | ||||||||||||||
Payments on finance leases | (125) | (159) | (1,303) | ||||||||||||||
Net cash provided by financing activities | 210,906 | 168,237 | 82,001 | ||||||||||||||
Effects of exchange rate changes on cash | 225 | (20) | — | ||||||||||||||
Net change in cash, cash equivalents, and restricted cash equivalents | 89,881 | 99,560 | (13,347) | ||||||||||||||
Cash, cash equivalents, and restricted cash equivalents, beginning of year | 109,035 | 9,475 | 22,822 | ||||||||||||||
Cash, cash equivalents, and restricted cash equivalents, end of year | $ | 198,916 | $ | 109,015 | $ | 9,475 | |||||||||||
Reconciliation to amounts on the consolidated balance sheets: | |||||||||||||||||
Cash and cash equivalents | $ | 198,240 | $ | 95,260 | $ | 9,245 | |||||||||||
Current portion of restricted cash equivalents | — | — | — | ||||||||||||||
Non-current portion of restricted cash equivalents | 676 | 13,775 | 230 | ||||||||||||||
Total cash, cash equivalents, and restricted cash equivalents shown in the consolidated statements of cash flows | $ | 198,916 | $ | 109,035 | $ | 9,475 |
Year Ended December 31, | |||||||||||||||||
2024 | 2023 | 2022 | |||||||||||||||
(Unaudited) | |||||||||||||||||
Supplemental disclosures of cash flow information: | |||||||||||||||||
Cash paid for interest | $ | 6,337 | $ | 11,984 | $ | 4,364 | |||||||||||
Cash paid for income taxes | $ | 2,717 | $ | 2,356 | $ | 1,044 | |||||||||||
Noncash investing and financing activities: | |||||||||||||||||
Conversion of Series A Preferred Stock to Class A common stock | $ | 14,187 | $ | 10,755 | $ | — | |||||||||||
Debt discount through issuance of common stock warrants | $ | — | $ | 4,136 | $ | — | |||||||||||
Issuance of Class A Common Stock to settle commitment shares related to the ELOC program | $ | — | $ | 915 | $ | — | |||||||||||
Issuance of Class A Common Stock to settle obligations under Amelia Debt | $ | 11,817 | $ | — | $ | — | |||||||||||
Issuance of Class A Common Stock to settle contingent holdback consideration of SYNQ3 acquisition | $ | 189 | $ | — | $ | — | |||||||||||
Conversion of redeemable convertible preferred stock to common stock pursuant to Business Combination | $ | — | $ | — | $ | 279,503 | |||||||||||
Conversion of convertible note into common stock pursuant to Business Combination | $ | — | $ | — | $ | 20,239 | |||||||||||
Operating lease liabilities arising from obtaining right-of-use assets | $ | 1,559 | $ | — | $ | 650 | |||||||||||
Deferred offering costs reclassified to additional paid-in capital | $ | 220 | $ | — | $ | — | |||||||||||
Fair value of Class A common stock and deferred equity consideration issued for SYNQ3 acquisition | $ | 9,687 | $ | — | $ | — | |||||||||||
Fair value of contingent earnout consideration under SYNQ3 and Amelia acquisitions | $ | 286,898 | $ | — | $ | — | |||||||||||
Fair value of contingent holdback consideration under SYNQ3 acquisition | $ | 570 | $ | — | $ | — | |||||||||||
Fair value of deferred cash consideration under other acquisition | $ | 195 | $ | — | $ | — |